Study on the combined utilization of new drug expedited programs in America: the empirical analysis of osimertinib's R&D and application processDING Jin-xi, LI Peng-hui, YAO Xue-fang1-7
Analysis of Chinese invention patents for oral osmotic pump controlled release preparationHONG Li-juan, LIU Rui-hua, CUI Chuan-ming, YANG Yun-yun12-16
Introduction of the guidance on the estimation of measurement uncertainty of results for the determination of pesticide residuesPANG Yu, YU Xin-lan, LI Hai-fang, WANG Jing-wen, SUN Lei, MA Shuang-cheng17-21
Consideration on non-clinical evaluation of generic chemical injectionsNING Na, GUANG Hong-mei, WANG Qing-li22-25
An example for retriving reference medicinal products for marketing authorisation application of generic medicinal products in the EUXU Ming-di, NIU Jian-zhao, YANG Dong-sheng, LI Tao, QIAO Li-tao, GAO Tian-tian26-30
HPLC determination of zanamivir content and the related substancesDONG Hong, ZHANG Huan-huan, HUANG Qing, CAO Ri-sheng, ZHOU Ya, HU Yi-qiao31-37
Determination of the spray pattern and plume geometry of ipratropium bromide inhalation aerosolWEI Ning-yi, GAO Lei, ZHOU Ying, LIN Lan, NING Bao-ming38-42
Study on the optimization of cimetidine therapeutic scheme against irradiation in miceLIU Yu-ming, HE Ying, ZHAO Yi-ning, YUAN Wei-hong, SHEN Xian-rong43-46
Research progress of biomarkers of drug-induced liver injuryLIU Xiao-qian, WU Wen-xiao, GENG Xing-chao, LI Bo47-52